Alnylam Pharmaceuticals, Inc. earnings per share and revenue

ALNY earnings per share for the last quarter are -0.13 USD whereas the estimation was -1.07 USD which accounts for 87.82% surprise. Company revenue for the same period amounts to 659.83 M USD despite the estimated figure of 447.22 M USD. Estimated earnings per share for the next quarter are -0.91 USD, and revenue is expected to reach 527.81 M USD. Also watch annual changes over time to get a bigger picture of ALNY earnings per share and revenue dynamics.